We are live on
!
Find out more
DexCom
DXCM
DXCM
418 hedge funds and large institutions have $13.3B invested in DexCom in 2019 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 151 increasing their positions, 148 reducing their positions, and 90 closing their positions.
New
Increased
Maintained
Reduced
Closed
26% more capital invested
Capital invested by funds: $10.6B → $13.3B (+$2.72B)
7% more call options, than puts
Call options by funds: $68M | Put options by funds: $63.5M
2% more repeat investments, than reductions
Existing positions increased: 151 | Existing positions reduced: 148
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
4.65% less ownership
Funds ownership: 394.52% → 389.87% (-4.7%)
8% less funds holding
Funds holding: 456 → 418 (-38)
36% less first-time investments, than exits
New positions opened: 58 | Existing positions closed: 90
Holders
418
Holders Change
-38
Holders Change %
-8.33%
% of All Funds
9.08%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
58
Increased
151
Reduced
148
Closed
90
Calls
$68M
Puts
$63.5M
Net Calls
+$4.56M
Net Calls Change
-$25.7M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$537M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$153M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$132M |
| 4 |
Jennison Associates
New York
|
+$119M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$117M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$214M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$123M |
| 3 |
Renaissance Technologies
New York
|
-$121M |
| 4 |
HM
HealthCor Management
New York
|
-$87M |
| 5 |
MSE
MUFG Securities EMEA
London,
United Kingdom
|
-$69.5M |
